2792TiP A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC)
Year: 2025
Type: article
Source: Annals of Oncology
Institutions: Sheba Medical Center, Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Hackensack University Medical Center, Sarah Cannon, Fundación Arturo López Pérez, Shaare Zedek Medical Center, Bikur Cholim Hospital, Rambam Health Care Campus, Dana-Farber Cancer Institute, Vall d'Hebron Hospital Universitari, Ankara Bilkent City Hospital, National Cancer Center Hospital East, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Seoul National University, Seoul National University Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), Samsung Medical Center
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415939702